An official website of the United States government

Here's how you know

Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

COVID-19

Expand for resources

PAS-19-316 - Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

On This Page: 2

Active NOSIs

Title	Notice Number	Organization	Release Date	Expiration Date	Activity Code(s)
Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence Tools for Improved Assessment in Epidemiological, Clinical, and Intervention Research	NOT-CA-22-037	NCI , NHLBI , NIA , NIDA , NIMH , NINR , OBSSR	Jan 27, 2022	Mar 9, 2024	R01, R03, R21, R43/R44, R41/R42, R33, R34, R61/R33

Title	Notice Number	Organization	Release Date	Expiration Date	Activity Code(s)
Notice of Correction to Award Project Period Information for PAS-19-316, "Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)	NOT-AG-22-011	NIA NINDS	Jan 24, 2022	n/a	R43/R44